The effects of early and late bone marrow transplantation in siblings with alpha-mannosidosis. Is early haematopoietic cell transplantation the preferred treatment option?

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages

  Broomfield, A A ^a,c   Chakrapani, A ^b   Wraith, J E ^a  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c Department of Metabolic Disease Great Ormond Street Hospital for Children NHS Trust ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT DEVELOPMENT; ALPHA-MANNOSIDOSIS; CASE REPORT; CHILD DEVELOPMENT; COMPLICATION; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HUMAN; INFANT; MALE; PATHOPHYSIOLOGY; PATIENT SELECTION; PEDIGREE; PHENOTYPE; PSYCHOLOGY; RISK FACTOR; SIBLING; TIME; TIME TO TREATMENT; TREATMENT OUTCOME; ARTICLE; MANNOSIDOSIS; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ALPHA-MANNOSIDOSIS; CHILD DEVELOPMENT; GENETIC PREDISPOSITION TO DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HUMANS; INFANT; MALE; PATIENT SELECTION; PEDIGREE; PHENOTYPE; RISK FACTORS; SIBLINGS; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84897923340     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-9035-4     Document Type: Article

References (37)

1. Abraham D, Muir H, Olsen I, Winchester B (1985) Direct enzyme transfer from lymphocytes corrects a lysosomal storage disease. Biochem Biophys Res Commun 129:417-425
2. Albert MH, Schuster F, Peters C et al. (2003) T cell depleted peripheral blood stem cell transplantation for α-mannosidosis. Bone Marrow Transplant 32:443-446
3. Ara JR, Mayayo E, Marzo ME, Guelbenzu S, Chabis A, Pina MA, Calderon C (1999) Neurological impairment in α-mannosidosis: a longitudinal clinical and MRI study of a brother and sister. Childs Nerv Syst 15:369-371
4. Bahr BA, Bendiske J (2002) The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83:481-489
5. Berg T, Riise HM, Hansen GM, Malm D, Tranebbjarg L, Tollersrud OK (1999) Spectrum of mutations in alpha-mannosidosis. Am J Hum Genet 64:77-88
6. Blanz J, Stroobants S, Lullmann-Rauch R et al. (2008) Reversal of peripheral and central neuronal storage and ataxia after recombinant enzyme replacement therapy in α-mannosidosis mice. Hum Mol Genet 17:3437-3445
7. Boelens JJ, Wynn RF, O'Meara A et al. (2007) Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 40:225-233
8. Chester MA, Lundblad A, Ockerman PA, Autio S (1982) Mannosidosis. In: Durand P, O'Brien JS (eds) Genetic errors in glycoprotein metabolism. Springer, Berlin, p 89
9. Clark GF, Patankar MS (1998) Response to a letter to Glyco-Forum entitled "Hypothesis: immunodeficiencies ina-mannosidosis, my-cosis, AIDS and cancer-Acommon mechanism of inhibition of the functionof the lectin interleukin 2 by oligomannosides". Glycobiology 8:iii-iv
10. Crawley AC, Walkley SU (2007) Developmental analysis of CNS pathology in the lysosomal storage disease α-mannosidosis. J Neuropathol Exp Neurol 66:687-697
11. Dietmann JL, Flippi de la Palavesa MM, Tranchant C, Kastler B (1990) MR findings in mannosidosis. Neuroradiology 32:485-487, PMID 2287376
12. Dobrenis K (1992) Mechanisms underlying successful treatment of neuronal storage disease. Abstract: 034 of the 7th International Congress of Inborn Errors of Metabolism, Vienna, Austria
13. Futerman AH, van Meer G (2004) The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol 5:554-565
14. Grewal SS, Shapiro EG, Krivit W et al. (2004) Effective treatment of α-mannosidosis by allogeneic haematopoietic stem cell transplantation. J Pediatr 144:569-573
15. Hansen MD, Filipovich AH, Davies SM et al. (2008) Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen. Bone Marrow Transplant 41:349-353
16. Hickey WF, Kimura H (1998) Perivascular microglial cells of the CNS are bone derived and present in vivo. Science 239:290-292
17. Hoffmann B, Keshav S (2007) Gastrointestinal symptoms in Fabry disease: everything is possible, including treatment. Acta Paediatr Suppl 96:84-86, PMID 17391450
18. Jeyakumar M, Dwek RA, Butters TD, Platt FM (2005) Storage solutions treating lysosomal disorders of the brain. Nat Rev Neurosci 6:713-725
19. Kakkis ED, Muenzer J, Tiller GE, Waber L et al. (2001) Enzyme replacement therapy in mucopolysaccharidosis. N Eng J Med 344:1831-1888
20. Kennedy DW, Abkowitz JL (1997) Kinetics of central nervous system miroglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90:986-993
21. Kharbanda S, Panoskaltis-Moratari A, Haddad IY et al. (2006) Inflammatory cytokines and the development of Pulmonary complications after allogeneic Hematopoietic Cell transplantation in patients with inherited metabolic storage disorders. Biol Blood Marrow Transplant 12:430-437
22. Knoll RB, Kulkarni R, Netzloff ML (1986) Follow up of language and cognitive development in patients with mannosidosis. Arch Neurol 43:157-159
23. Malm D, Pantel J, Linaker OM (2005) Psychiatric symptoms in alphamannosidosis. J Intellect Disabil Res 49:865-871
24. Miano M, Labopin M, Hartmann O et al. (2007) Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 39:89-99
25. Michalski JC, KleinA(1999)Glycoprotein lysosomal storage disorders: α-And β-mannosidosis, fucosidosis and α-N- Acetylgalactosaminidase deficiency. Biochem Biophys Acta 1455:69-84
26. Mitchell ML, Erickson RP, Schmid D, Hieber V, Poznanski AK, Hicks SP (1981) Mannosidosis: two brothers with different degrees of disease severity. Clin Genet 20:191-202
27. O'Brien T, Eastlund T, Peters C, Neglia JP, Defor T, Ramsay NKC, Baker KS (2004) Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated transplants for non-malignant diseases. Br J Haematol 127:67-75
28. Peters CJ (2003) Effective treatment of the central nervous system in lysosomal storage diseases: save that brain. J Lab Clin Med 142:361-363
29. Roces DP, Lüllmann-Rauch R, Peng J et al. (2004) Efficacy of enzyme replacement therapy in α-mannosidosis mice: a preclinical animal study. Hum Mol Genet 13:1979-1988
30. Spranger J, Gehler J, Cantz M (1976) The radiographic features of α-mannosidosis. Radiology 119:401
31. Staba SL, Escolar ML, Poe M et al. (2004) Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 350:1932-1934
32. Sun H, Wolfe JH (2001) Recent progress in lysosomal α-mannosidosis and its deficiency. Exp Mol Med 33:1-7
33. Thomas G (2001) Disorders of glycoprotein degradation: α-mannosidosis, β-mannosidosis, fucosidosis and sialidosis. In: Scriver CR, Beaudet al., Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited metabolic disease, 8th edn. McGraw-Hill Medical, pp 3507-3516
34. Vite CH, McGowan JC, Niogi SN, Passini MA, Drobatz KJ, Haskins ME, Wolfe JH (2005) Effective gene therapy for an inherited metabolic disease in a large animal model. Ann Neurol 57:355-364
35. Walkley SU (2004) Pathogenic cascades and brain dysfunction. In: Platt FM, Walkley SU (eds) Lysosomal disorders of the brain. Oxford University Press, New York, p 290-324
36. Walkley SU (2007) Pathological mechanisms in lysosomal disease: a reappraisal of the role of the lysosome. Acta Paediatr 96:26-32
37. Walkley SU, Dobrenis K (1995) Bone marrow transplantation for the treatment of lysosomal storage disorders. Lancet 345:1398-1402